Introduction Over the past two decades, transcatheter aortic valve replacement (TAVR) has
expanded its application across all surgical risk levels, including low-risk patients, where …

Conduction disturbances (CDs) are common after transcatheter aortic valve replacement.
Continuous improvements in preprocedural planification, implant techniques, and device …

The long-term safety and effectiveness of transcatheter aortic valve replacement (TAVR)
compared with surgical aortic valve replacement (SAVR) in low surgical risk has not been …

Background Conduction disturbances requiring a permanent pacemaker (PPM) are a
frequent complication of transcatheter aortic valve replacement (TAVR) with few reports of …

Background: The Myval balloon-expandable (BE) valve has shown encouraging early
clinical data in terms of safety and efficacy. Comparative data with other well-established …

Aims Conduction abnormalities necessitating permanent pacemaker (PPM) implantation
remain the most frequent complication post-transcatheter aortic valve implantation (TAVI) …

Transcatheter aortic valve replacement (TAVR) has increasingly become a safe, feasible,
and widely accepted alternative surgical treatment for patients with severe symptomatic …

Background The impact of prosthesis-patient mismatch (PPM) on major endpoints after
transcatheter aortic valve replacement (TAVR) is controversial and the effects on …

Background Transcatheter aortic valve replacement (TAVR) has evolved as a breakthrough
therapy for patients with severe aortic valve stenosis. While TAVR has revolutionized the …

Transfemoral transcatheter aortic valve Replacement (TAVR) has become the standard
therapy for patients with severe aortic stenosis in patients over 75 years old in Europe or 65 …